Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Corneal Neovascularization With or Without Concomitant Inflammation and/or Infection

NCT04787471 is registered in ClinicalTrials.gov with Price Vision Group as lead sponsor.

NCT NCT04787471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04787471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Corneal Neovascularization With or Without Concomitant Inflammation and/or Infection
Lead sponsor
Price Vision Group
Phase
Phase 2/3
Overall status
Recruiting
Start date
May 3, 2021
Completion date
September 15, 2029
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal neovascularization